Magrolimab (anti-CD47)

製品コード：A2036         Batch: A203602

印刷

Magrolimab (anti-CD47) (5F9, GS-4721,Hu5F9 G4,ONO 7913) is a first-in-class macrophage immune checkpoint inhibitor that mainly binds to N-terminal pyroglutamate of CD47.

製品説明

CAS No. 2169232-81-7
Formulation PBS Buffer, PH 7.4
Isotype Human IgG4
Application Magrolimab (anti-CD47)
Source CHO cells
Storage
(From the date of receipt)		 Store the undiluted solution at 4°C in the dark to avoid freeze-thaw cycles.
Shipping Shipped under low temperature conditions
Purity 99%
Protein concentration 6.05mg/ml
Endotoxin Level <1 EU/mg

カスタマーフィードバック

A2036-Magrolimab-(anti-CD47).gif

Selleckの高級品が、幾つかの出版された研究調査結果（以下を含む）で使われた：

The "don't eat me" signal CD47 is associated with microglial phagocytosis defects and autism-like behaviors in 16p11.2 deletion mice [ Proc Natl Acad Sci U S A, 2025, 122(16):e2411080122] PubMed: 40238451
Maplirpacept: a CD47 decoy receptor with minimal red blood cell binding and robust anti-tumor efficacy [ Front Immunol, 2025, 16:1518787] PubMed: 40078999

人間や獣医の診断であるか治療的な使用のためにでない。